Position in JANX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$11,142,877
+$953,926 QoQ
Shares Held
801,646
+8.6% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. JANX ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in JANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,142,877 | 801,646 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $10,188,951 | 738,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,059,965 | 493,452 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $19,852,668 | 859,423 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,231,802 | 749,326 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $42,551,501 | 794,761 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,852,956 | 62,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,001,454 | 119,395 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $886,317 | 23,541 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $469,983 | 43,801 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $307,842 | 30,540 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $251,011 | 21,147 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $287,216 | 23,737 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $243,617 | 18,498 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $205,225 | 15,157 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $311,573 | 25,518 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $590,218 | 41,159 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $150,617 | 7,634 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $63,654 | 2,943 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $51,096 | 2,048 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||